{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:51:04Z","timestamp":1790761864435,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017585","name":"First Hospital of Jilin University","doi-asserted-by":"publisher","award":["JDYY-TRP-2025002"],"award-info":[{"award-number":["JDYY-TRP-2025002"]}],"id":[{"id":"10.13039\/501100017585","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202879"],"award-info":[{"award-number":["82202879"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202301ZYTS100"],"award-info":[{"award-number":["YDZJ202301ZYTS100"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.colsurfb.2025.115088","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:07:49Z","timestamp":1756480069000},"page":"115088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Biomimetic LHRH-functionalized erythrocyte-camouflaged nanogels for targeted therapy of prostate cancer"],"prefix":"10.1016","volume":"257","author":[{"given":"Min","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2025.115088_bib1","first-page":"17","volume":"73","author":"Siegel","year":"2023","journal-title":"Cancer Stat."},{"key":"10.1016\/j.colsurfb.2025.115088_bib2","first-page":"162","volume":"523","author":"de Porras","year":"2021","journal-title":"Chemotherapy metastatic castrationresistant prostate cancer current scenario future perspectives"},{"key":"10.1016\/j.colsurfb.2025.115088_bib3","first-page":"221","volume":"20","author":"Nader","year":"2018","journal-title":"Role of chemotherapy in prostate cancer"},{"key":"10.1016\/j.colsurfb.2025.115088_bib4","first-page":"1159","volume":"37","author":"Rosenthal","year":"2019","journal-title":"Effect chemotherapy docetaxel androgen suppression radiotherapy localized highrisk prostate cancer randomized phase III NRG oncology RTOG 0521 trial"},{"key":"10.1016\/j.colsurfb.2025.115088_bib5","volume":"110","author":"Fallara","year":"2022","journal-title":"Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis"},{"key":"10.1016\/j.colsurfb.2025.115088_bib6","first-page":"351","volume":"6","author":"Manzari","year":"2021","journal-title":"Targeted drug delivery strategies for precision medicines"},{"key":"10.1016\/j.colsurfb.2025.115088_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-33-4497-6","volume":"62","author":"Shah","year":"2021","journal-title":"Technology, nanocarriers for targeted drug delivery"},{"key":"10.1016\/j.colsurfb.2025.115088_bib8","first-page":"2039","volume":"17","author":"Xu","year":"2023","journal-title":"Quantitative comparison gold nanoparticle delivery via enhanced permeation retention (EPR) effect mesenchymal stem cell (MSC)based targeting"},{"key":"10.1016\/j.colsurfb.2025.115088_bib9","volume":"188","author":"Zi","year":"2022","journal-title":"Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms"},{"key":"10.1016\/j.colsurfb.2025.115088_bib10","first-page":"512","volume":"345","author":"Ikeda-Imafuku","year":"2022","journal-title":"Strategies to improve the EPR effect: a mechanistic perspective and clinical translation"},{"key":"10.1016\/j.colsurfb.2025.115088_bib11","first-page":"1685","volume":"23","author":"Mundekkad","year":"2022","journal-title":"Nanoparticles in clinical translation for cancer therapy"},{"key":"10.1016\/j.colsurfb.2025.115088_bib12","first-page":"57","volume":"2","author":"Zheng","year":"2021","journal-title":"Challenges and opportunities of nanomedicines in clinical translation"},{"key":"10.1016\/j.colsurfb.2025.115088_bib13","first-page":"33","volume":"20","author":"Fang","year":"2023","journal-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles"},{"key":"10.1016\/j.colsurfb.2025.115088_bib14","volume":"11","author":"Zhang","year":"2021","journal-title":"Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics"},{"key":"10.1016\/j.colsurfb.2025.115088_bib15","first-page":"5187","volume":"17","author":"Nguyen","year":"2023","journal-title":"Advances in drug delivery systems based on red blood cells and their membrane-derived nanoparticles"},{"key":"10.1016\/j.colsurfb.2025.115088_bib16","first-page":"1","volume":"19","author":"Wu","year":"2021","journal-title":"Biomimetic recombinant of red blood cell membranes for improved photothermal therapy"},{"key":"10.1016\/j.colsurfb.2025.115088_bib17","first-page":"805","volume":"19","author":"Liu","year":"2022","journal-title":"Photolytic removal of red blood cell membranes camouflaged on nanoparticles for enhanced cellular uptake and combined chemo-photodynamic inhibition of cancer cells"},{"key":"10.1016\/j.colsurfb.2025.115088_bib18","first-page":"744","volume":"345","author":"Song","year":"2022","journal-title":"Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers"},{"key":"10.1016\/j.colsurfb.2025.115088_bib19","volume":"14","author":"Malhotra","year":"2022","journal-title":"Nanobiotechnology Red blood cells membranederived nanoparticles applications key challenges their clinical translation"},{"key":"10.1016\/j.colsurfb.2025.115088_bib20","first-page":"2857","volume":"2","author":"Ding","year":"2011","journal-title":"One-step preparation of reduction-responsive poly (ethylene glycol)-poly (amino acid) s nanogels as efficient intracellular drug delivery platforms"},{"key":"10.1016\/j.colsurfb.2025.115088_bib21","first-page":"633","volume":"1","author":"Ding","year":"2013","journal-title":"Enhanced endocytosis of acid-sensitive doxorubicin derivatives with intelligent nanogel for improved security and efficacy"},{"key":"10.1016\/j.colsurfb.2025.115088_bib22","first-page":"136","volume":"259","author":"Guo","year":"2017","journal-title":"Positively charged polypeptide nanogel enhances mucoadhesion and penetrability of 10-hydroxycamptothecin in orthotopic bladder carcinoma"},{"key":"10.1016\/j.colsurfb.2025.115088_bib23","first-page":"183","volume":"36","author":"Wang","year":"2016","journal-title":"Enhanced drug loading capacity of 10-hydroxycamptothecin-loaded nanoparticles prepared by two-step nanoprecipitation method"},{"key":"10.1016\/j.colsurfb.2025.115088_bib24","first-page":"6225","volume":"11","author":"Rao","year":"2015","journal-title":"Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance"},{"key":"10.1016\/j.colsurfb.2025.115088_bib25","first-page":"6386","volume":"15","author":"Kim","year":"2021","journal-title":"Coagulation-inspired direct fibrinogen assay using plasmonic nanoparticles functionalized with red blood cell membranes"},{"key":"10.1016\/j.colsurfb.2025.115088_bib26","first-page":"6527","volume":"16","author":"Miao","year":"2022","journal-title":"Cell membrane-camouflaged nanocarriers with biomimetic deformability of erythrocytes for ultralong circulation and enhanced cancer therapy"},{"key":"10.1016\/j.colsurfb.2025.115088_bib27","first-page":"1843","volume":"70","author":"Mohammad-Rafiei","year":"2023","journal-title":"Biochemistry, Cell membrane biomimetic nanoparticles in drug delivery"},{"key":"10.1016\/j.colsurfb.2025.115088_bib28","first-page":"1","author":"Ma","year":"2022","journal-title":"Hydroxycamptothecin (HCPT)loaded PEGlated lipidpolymer hybrid nanoparticles effective delivery HCPT QbDbased development evaluation"},{"key":"10.1016\/j.colsurfb.2025.115088_bib29","first-page":"965","volume":"19","author":"Wang","year":"2022","journal-title":"Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics"},{"key":"10.1016\/j.colsurfb.2025.115088_bib30","first-page":"3549","volume":"25","author":"Gao","year":"2013","journal-title":"Surface functionalization of gold nanoparticles with red blood cell membranes"},{"key":"10.1016\/j.colsurfb.2025.115088_bib31","volume":"27","author":"Sun","year":"2017","journal-title":"Cancer cell membrane-coated gold nanocages with hyperthermia-triggered drug release and homotypic target inhibit growth and metastasis of breast cancer"},{"key":"10.1016\/j.colsurfb.2025.115088_bib32","first-page":"82","volume":"116","author":"Zhao","year":"2017","journal-title":"Targeted hydroxyethyl starch prodrug for inhibiting the growth and metastasis of prostate cancer"},{"key":"10.1016\/j.colsurfb.2025.115088_bib33","first-page":"1040","volume":"42","author":"Zhang","year":"2021","journal-title":"Surface loading nanoparticles engineered natural erythrocytes prolonged circulation time strategies applications"},{"key":"10.1016\/j.colsurfb.2025.115088_bib34","first-page":"1104","volume":"83","author":"Hu","year":"2012","journal-title":"Nanoparticle-based combination therapy toward overcoming drug resistance in cancer"},{"key":"10.1016\/j.colsurfb.2025.115088_bib35","volume":"30","author":"Fang","year":"2018","journal-title":"Cell membrane coating nanotechnology"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525005958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776525005958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:32:04Z","timestamp":1772821924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776525005958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"alternative-id":["S0927776525005958"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115088","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic LHRH-functionalized erythrocyte-camouflaged nanogels for targeted therapy of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.115088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115088"}}